Literature DB >> 16682809

JNK regulation of oncogenesis.

Lynn E Heasley1, Sun-Young Han.   

Abstract

The literature provides strong precedent for both pro-tumorigenic and tumor suppressor roles for the c-Jun N-terminal kinases (JNKs) in the setting of oncogenesis. Clearly, JNKs are activated by numerous oncogenes and growth factors and the literature documents a role for these MAP kinases in cell proliferation and transformation. By contrast, JNKs mediate signals from diverse stimuli that result in cell death or differentiation and a role for JNKs as tumor suppressors has emerged. This enigmatic nature of the JNKs in the setting of oncogenesis is considered herein. Further illumination of the complex and context-dependent functions of the JNKs in cancer cells is of obvious importance for the rational use of small molecule JNK inhibitors as therapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682809

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  27 in total

Review 1.  The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.

Authors:  Gary L Johnson; Kazuhiro Nakamura
Journal:  Biochim Biophys Acta       Date:  2007-01-04

2.  Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish.

Authors:  Nitixa Patel; Tilman E Klassert; Steven J Greco; Shyam A Patel; Jessian L Munoz; Bobby Y Reddy; Margarette Bryan; Neil Campbell; Natalia Kokorina; Hatem E Sabaawy; Pranela Rameshwar
Journal:  Stem Cells Dev       Date:  2011-07-26       Impact factor: 3.272

3.  Posttranslational modification of vesicular stomatitis virus glycoprotein, but not JNK inhibition, is the antiviral mechanism of SP600125.

Authors:  Sabrina Marozin; Jennifer Altomonte; Sibylle Apfel; Phat X Dinh; Enrico N De Toni; Antonia Rizzani; Andreas Nüssler; Nobuyuki Kato; Roland M Schmid; Asit K Pattnaik; Oliver Ebert
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  MAP kinase genes and colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Roger K Wolff
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

5.  c-Jun N-terminal kinase is involved in the regulation of proliferation and apoptosis by integrin-linked kinase in human retinoblastoma cells.

Authors:  Zhen Chen; Anhuai Yang; Chong Xu; Yiqiao Xing; Wenrong Gong; Junping Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-14       Impact factor: 3.117

6.  CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation.

Authors:  C P El-Haibi; R Singh; P K Sharma; S Singh; J W Lillard
Journal:  Cell Prolif       Date:  2011-06-06       Impact factor: 6.831

7.  Oral administration of blueberry inhibits angiogenic tumor growth and enhances survival of mice with endothelial cell neoplasm.

Authors:  Gayle Gordillo; Huiqing Fang; Savita Khanna; Justin Harper; Gary Phillips; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

8.  Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.

Authors:  Hazem Khalaf; Jana Jass; Per-Erik Olsson
Journal:  BMC Immunol       Date:  2010-05-27       Impact factor: 3.615

9.  Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators.

Authors:  S E Wang; Y Yu; T L Criswell; L M Debusk; P C Lin; R Zent; D H Johnson; X Ren; C L Arteaga
Journal:  Oncogene       Date:  2010-04-12       Impact factor: 9.867

Review 10.  Non-classical p38 map kinase functions: cell cycle checkpoints and survival.

Authors:  Tina M Thornton; Mercedes Rincon
Journal:  Int J Biol Sci       Date:  2008-12-19       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.